General Information of the Compound
Compound ID
CP0450182
Compound Name
US8969325, 18
    Show/Hide
Synonyms
PMID25666693-Compound-33
    Show/Hide
Structure
Formula
C21H21F3N4O3
Molecular Weight
434.418
Canonical SMILES
CN1Cc2ccc(NC(=O)N[C@@H]3C[C@@](C)(Oc4ccccc34)C(F)(F)F)cc2NC1=O
    Show/Hide
InChI
InChI=1S/C21H21F3N4O3/c1-20(21(22,23)24)10-16(14-5-3-4-6-17(14)31-20)26-18(29)25-13-8-7-12-11-28(2)19(30)27-15(12)9-13/h3-9,16H,10-11H2,1-2H3,(H,27,30)(H2,25,26,29)/t16-,20-/m1/s1
    Show/Hide
InChIKey
OFCQSAHGUNDUTK-OXQOHEQNSA-N
Physicochemical Property
logP
4.6302
Rotatable Bonds
2
Heavy Atom Count
31
Polar Areas
82.7
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
3
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71611619
ChEMBL ID
CHEMBL3677317
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 48 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PMID25666693-Compound-33 )
Drug Name PMID25666693-Compound-33
Company ABBVIE INC
Indication
Osteoarthritis pain
Patented
Cancer related pain
Patented
Neuropathic pain
Patented
Inflammatory pain
Patented
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Antagonist